Effect of GLP-1 on Angiogenesis

NCT02686177 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Liraglutide
DRUG: Metformin or sulfonylurea

Sponsor

Assistance Publique - Hôpitaux de Paris